Skip to content
中文产业新闻精选评分70Chinese source

礼来匹妥布替尼获 FDA 批准用于 CLL/SLL 一线治疗

礼来「匹妥布替尼」获 FDA 批准新适应症

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.